← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Applied Biotechnology Institute
San Luis Obispo, CA
$4,687,270
Total funding
7
Grants
Funding over time
peak $943.2K · FY2008–22$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$4,539,995 · 6
CDC$147,275 · 1
By mechanism
R44$2,582,770 · 1
R43$1,654,516 · 5
N43$449,984 · 1
Investigators at Applied Biotechnology Institute
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
An Orally Delivered Booster Vaccine Candidate for Hepatitis B$943,211
R44 · FY2012 · AI
An Orally Delivered Booster Vaccine Candidate for Hepatitis B$911,830
R44 · FY2013 · AI
An Orally Delivered Booster Vaccine Candidate for Hepatitis B$727,729
R44 · FY2014 · AI
A MUCOSAL PROPHYLACTIC VACCINE AGAINST COCCIDIOIDOMYCOSIS$449,984
N43 · FY2016 · AI
Low-cost Production of a Vaccine for Lyme Disease in Maize$310,667
R43 · FY2022 · AI
An Orally Delivered Hepatitis B Vaccine$295,299
R43 · FY2009 · AI
An Orally Delivered Hepatitis B Vaccine$295,171
R43 · FY2008 · AI
Low-cost Production of a Vaccine for Lyme Disease in Maize$282,857
R43 · FY2021 · AI
Production of stabilized trimeric HIV Env protein in maize$149,928
R43 · FY2017 · AI
Production of immunogenic Ebola GP protein in maize$147,275
R43 · FY2016 · CK
Improving the efficacy of hepatitis B prophylactic vaccines$146,776
R43 · FY2016 · DK
An Orally Delivered Hepatitis B Vaccine$26,543
R43 · FY2009 · AI